Cathie Wood Intellia Therapeutics, Inc. Transaction History
Ark Investment Management LLC
- $14 Billion
- Q1 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 10,989,282 shares of NTLA stock, worth $288 Million. This represents 2.16% of its overall portfolio holdings.
Number of Shares
10,989,282
Previous 11,412,449
3.71%
Holding current value
$288 Million
Previous $348 Million
13.12%
% of portfolio
2.16%
Previous 2.09%
Shares
30 transactions
Others Institutions Holding NTLA
# of Institutions
311Shares Held
89.2MCall Options Held
686KPut Options Held
599K-
Black Rock Inc. New York, NY9.11MShares$239 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$238 Million0.01% of portfolio
-
State Street Corp Boston, MA4.6MShares$121 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.21MShares$110 Million3.83% of portfolio
-
Wellington Management Group LLP Boston, MA4.16MShares$109 Million0.02% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.99B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...